ANTHONY F. YACONA, M. D.

1515 N. Federal Highway, Suite 215

Boca Raton, Florida 33432

  

EDUCATION

1968                  Bachelor of Arts from Rutgers CollegeNew Brunswick, NJ

1973                           Doctor of Medicine from the University of Cincinnati, Cincinnati, Ohio

1973-1975         Adult Psychiatry Residency at Montifiore Hospital, Albert Einstein College of Medicine, Bronx, NY

1975-1976         Pediatric Residency at Mt Sinai Hospital, Mt Sinai School of Medicine, NY, NY

1976-1978         Child and Adolescent Psychiatry Fellowship at the College of Medicine and Dentistry of New Jersey, Piscataway, NJ

 

CERTIFICATIONS

1974                 National Board of Medical Examiners 

1979                 Adult Psychiatry by the American Board of Psychiatry and Neurology 

1982                 Child Psychiatry by the American Board of Psychiatry and Neurology  

 

PROFESSIONAL POSITIONS

1978-1980         Staff Psychiatrist at the Children’s Psychiatric Center, Monmouth County, NJ

1980-1981         Medical Director at the Children's Psychiatric Center, Monmouth County, NJ

1981-1985         Private practice of child and adult Psychiatry, Monmouth County, NJ

1985-1988         Chief of Child and Adolescent Psychiatry at Fair Oaks Hospital, Delray Beach, Fl

1987-1988         Director of Adolescent Substance Abuse Prevention and Treatment Program at Fair Oaks Hospital, Delray Beach, Fl

1986-1988         Director of Adolescent  Research, 1-800-COCAINE, Delray Beach, Fl

1988-1991         Vice Chairman of the Board of Trustees, University Pavilion Hospital, Tamarac, Fl          

1988-1991         Medical Director of the University Pavilion Hospital, Tamarac, Fl

1988-1993         Private practice of child and adult Psychiatry, Coral Springs, Fl

1992-1993                  Director of the Rapid Stabilization Program at CPC Fort Lauderdale Hospital, Fort Lauderdale, Fl

1992-1994         Medical Director of Rapha Southeast psychiatric services, Fort Lauderdale, Fl  

1993-1995                  Director of Adolescent Services and Partial Hospitalization Program at CPC Fort Lauderdale Hospital, Fort Lauderdale, Fl

1993-1995         Private Practice of Child and Adult Psychiatry, Ft. Lauderdale, Fl

1994-1995         Associate Medical Director at the American Day Treatment Center, Boca Raton, Fl

1995-1997         Medical Director at American Day Treatment Center, Boca Raton, Fl

1995-1996         Medical Director of Child and Adolescent Services at Fair Oaks Hospital, Delray Beach, Fl

1995-Present     Private Practice of Child and Adult Psychiatry, Boca Raton, Fl

1995-1997         Founder and Co-Director of the Family Institute of Boca Raton, Boca Raton, Fl

1997-Present     Founder and Vice President of Finance of Health Sciences America, Inc., Pharmaceutical Research Company, Boca Raton, Fl

1998-Present     Founder and Co-Director of Health Sciences Institute, Clinical Psychiatric Services, Boca Raton, Fl

2000-Present     Founder and Chairman of The Yacona Mental Health Foundation; Non-Profit Foundation for the improving care for those suffering from mental disorders, Boca Raton, Fl

2004-Present     Founder and Chairman of ThinkHealthy.org; Non-Profit Foundation for the improving care for those suffering from mental disorders, Boca Raton, Fl 

                         

SELECTED RESEARCH STUDIES IN PRESS  

1.       A prospective, multi-center, open-label study of Aripiprazole in the management of patients with schizophrenia or schizoaffective disorder in the general psychiatric practices.

2.       An international, multi-center, large simple trial (LST) to compare the cardiovascular safety of Ziprasidone and Olanzapine.

3.       Escitalopram effects on Quality of Life.

4.       “Nefazadone in the Treatment of Patients with Chronic Pain.”

5.       “A Double-Blind, Placebo-Controlled, Randomized Clinical Trial of the Efficacy of Sertraline in the Treatment of Dysthymia.”

6.       “Nefazadone in the Treatment of Agitated Geriatric Patients.”

7.       “A Placebo-Controlled Study of Olanzapine Monotherapy in the Treatment of Bipolar I Depression.”

8.       An Open-Label Combination of Olanzapine and Fluoxetine in Major Depressive Disorder.”

9.       “A Twelve-Week, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Efficacy and Tolerability of Paroxetine in Patients Suffering from Posttraumatic Stress Disorder (PTSD).”

10.   “A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of Two Doses of Aripiprazole in the Treatment of Hospitalized Patients with Acute Mania.”

11.   “A Multi-Center, Open-Label, Long-Term Study of the Safety, Tolerability and Efficacy of Aripiprazole in the Maintenance Treatment of Patients with Bipolar Disorders.”

12.  “An Open-Label Evaluation of Lamotrigine Versus Carbamapezine, Phenytoin, and Divalproex Sodium as Monotherapy Treatment for Epilepsy Patients Who Have Failed a Previous Course of Anti-Epileptic Drug Therapy.”       

 

 

Copyright © 2005 ThinkHealthy™ All Rights Reserved.
Last modified: January 27, 2008. WebSite by FuLabs™.